Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Multifocal visual evoked potential in optic neuritis, ischemic optic neuropathy and compressive optic neuropathy.
Quantitative analysis of the suppressors of cytokine signaling 1 and 3 in peripheral blood leukocytes of patients with multiple sclerosis.
Increased sleep fragmentation in experimental autoimmune encephalomyelitis.
Alpha beta-crystallin expression and presentation following infection with murine gammaherpesvirus 68.
Cognition, cognitive dysfunction, and cognitive rehabilitation in multiple sclerosis.
Multiple sclerosis (MS) for the urologist: What should urologists know about MS?
The effect of the sphingosine-1-phosphate analogue FTY720 on atrioventricular nodal tissue.
Reduced Myelin Water in the White Matter Tracts of Patients with Niemann-Pick Disease Type C.
Promising New Approaches to Assess Cognitive Functioning in People with Multiple Sclerosis.
Development of a Human Dihydroorotate Dehydrogenase (hDHODH) Pharma-Similarity Index Approach with Scaffold-Hopping Strategy for the Design of Novel Potential Inhibitors.
Acute disseminated encephalomyelitis following influenza vaccination.
White matter disease: Early treatment of inflammatory demyelinating disease.
Peptide-functionalized polymeric nanoparticles for active targeting of damaged tissue in animals with experimental autoimmune encephalomyelitis.
Olanzapine ameliorates neuropathological changes and increases IGF-1 expression in frontal cortex of C57BL/6 mice exposed to cuprizone.
[Effect of therapeutic apheresis on the lymphocyte sensitivity to corticosteroids in patients with secondary progressive multiple sclerosis.]
Botulinum neurotoxin-A treatment of lower urinary tract symptoms in multiple sclerosis.
Induction of endogenous Type I interferon within the central nervous system plays a protective role in experimental autoimmune encephalomyelitis.
Autoantibodies in neuroimmunological diseases; relevance of fine specificity.
"Response to the Commentary on "Neuromyelitis Optica: Potential Roles for Intravenous Immunoglobulin"
Preclinical and early clinical development of GNbAC1, a humanized IgG4 monoclonal antibody targeting endogenous retroviral MSRV-Env protein.
A rare association of tuberculous longitudinally extensive transverse myelitis (LETM) with brain tuberculoma.
Predictors of recurrence following an initial episode of transverse myelitis.
Adrenomedullin protects from experimental autoimmune encephalomyelitis at multiple levels.
Is the Iranian Revolution to Blame for the Increasing Incidence of Multiple Sclerosis in Iran?.
Global N-acetylaspartate concentration in benign and non-benign multiple sclerosis patients of long disease duration.
Pages
« first
‹ previous
…
489
490
491
492
493
494
495
496
497
…
next ›
last »